http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104027336-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56d4164e2c4f9b9b4d73cd8033675c0a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8c25e8a72b0f282b75074e029b14ae4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd93ff13ba2b06ad4ffcfbf616deecf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca6e699210f19ea71470b1eeb93178f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_477375a2f61f3d38325db5b7a6d59fbf |
publicationDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104027336-A |
titleOfInvention | Medicament composition of imatinib mesylate and preparation of medicament composition |
abstract | The invention relates to the field of medicaments, and in particular relates to a medicament composition of imatinib mesylate. The imatinib mesylate medicament composition comprises an imatinib mesylate hydrate, imatinib mesylate amorphous powder and medicament accessory materials. An X-ray powder diffraction diagram of the imatinib mesylate hydrate obtained by measurement of Cu-K alpha rays is shown in Figure 1. An imatinib mesylate compound disclosed by the invention has good stability, flowability, rapid dissolution and good clinical effects, and is very suitable for clinical applications. |
priorityDate | 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.